Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer

NCT03786575 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasm Female
Therapeutics
Mutation

Interventions

DIAGNOSTIC_TEST: Next Generation Sequencing (NGS) detection

Sponsor

Peking Union Medical College